Statistics for Co-Diagnostics (id:5835 CODX)

Valuation metrics

Market cap

32.25M

Enterprise value

-3,044,306.00

Trailing P/E (ttm)

-0.84

Forward P/E

-0.86

PEG ratio

-0.86

Price/Sales (ttm)

4.41

Price/Book (mrq)

0.51

Enterprise Value/Revenue

-0.42

Enterprise Value/EBITDA

0.08

Overview

Shares outstanding

31.93M

Float

30.21M

Shares short

208.70K

% Held by insiders

0.05%

% Held by institutions

0.14%

Average volume (10 days)

127.96K

Average volume (90 days)

Price summary

52-Week low

1.00

52-Week high

2.23

52-Week change

-6.93%

Beta

-0.85

50-Day moving average

1.21

200-Day moving average

1.22

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

38.57%

Operating margin

-1,596.36%

Operational effectiveness

Return on assets

-27.61%

Return on equity

-50.57%

Income statement

Revenue (ttm)

0.24

Revenue per share (ttm)

0.24

Quarterly revenue growth (yoy)

Gross profit (ttm)

2.63M

EBITDA

-38,666,460.00

Net income to common (ttm)

-41,284,272.00

Diluted EPS (ttm)

-1.38

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

37.66M

Total cash per share (mrq)

1.18

Total debt (mrq)

2.37M

Total Debt/Equity (mrq)

3.71

Current ratio (mrq)

691.70%

Book value per share (mrq)

2.00

Cash flow

Cash flow statement

-25,702,664.00

Levered free cash flow (LFCF)

-12,792,538.00